Login to Your Account

Evotec Taps Chinese Market via Conba Deal for EVT 401

By Nuala Moran
Staff Writer

Thursday, May 3, 2012
LONDON – Evotec AG landed its second out-licensing deal in China, taking a small up-front payment, with €60 million (US$78.8 million) to come in milestones, followed by double-digit royalties on sales if EVT 401 makes it through to Chinese marketing approval.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription